Rapid detection of AAV8 binding antibodies in gene therapy candidates: development of a point-of-care approach

by Biotech Newsroom


  • Rodrigues GA, Shalaev E, Karami TK, Cunningham J, Slater NKH, Rivers HM. Pharmaceutical development of AAV-based gene therapy products for the eye. Pharm Res. 2018;36:29.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Bougioukli S, Chateau M, Morales H, Vakhshori V, Sugiyama O, Oakes D, et al. Correction: limited potential of AAV-mediated gene therapy in transducing human mesenchymal stem cells for bone repair applications. Gene Ther. 2024;31:527.

    Article 
    CAS 
    PubMed 



  • Source link

    You may also like

    Houston, TX – (EmailWire) — The Biotech Times™ aggregates, publishes and distributes news about the Biotech Industry. In association with EmailWire™, The Biotech Times, helps businesses and organizations in the industry with press release distribution. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us through the following messaging apps:

    Free Magazines

    Recent Articles

    BioTech Times™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC